Recent KPTI News
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 07/01/2024 08:05:00 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/20/2024 12:01:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/10/2024 04:15:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:03:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:02:21 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates • PR Newswire (US) • 06/01/2024 05:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 12:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:32:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:32:34 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/30/2024 08:44:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/30/2024 08:06:36 PM
- Karyopharm to Participate at the Jefferies Global Healthcare Conference • PR Newswire (US) • 05/29/2024 08:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/23/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:13:19 PM
- Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:52:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:47:54 AM
- Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029 • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:56:19 PM
- Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024 • PR Newswire (US) • 05/02/2024 08:30:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/01/2024 08:05:00 PM
- Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting • PR Newswire (US) • 04/24/2024 08:01:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM